Your browser doesn't support javascript.
loading
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.
Henao-Restrepo, Ana Maria; Longini, Ira M; Egger, Matthias; Dean, Natalie E; Edmunds, W John; Camacho, Anton; Carroll, Miles W; Doumbia, Moussa; Draguez, Bertrand; Duraffour, Sophie; Enwere, Godwin; Grais, Rebecca; Gunther, Stephan; Hossmann, Stefanie; Kondé, Mandy Kader; Kone, Souleymane; Kuisma, Eeva; Levine, Myron M; Mandal, Sema; Norheim, Gunnstein; Riveros, Ximena; Soumah, Aboubacar; Trelle, Sven; Vicari, Andrea S; Watson, Conall H; Kéïta, Sakoba; Kieny, Marie Paule; Røttingen, John-Arne.
Afiliação
  • Henao-Restrepo AM; World Health Organization, Geneva, Switzerland.
  • Longini IM; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
  • Dean NE; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Edmunds WJ; Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Camacho A; Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Carroll MW; Public Health England, Porton Down, Wiltshire, UK; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Doumbia M; Centre pour Développement des Vaccins, Bamako, Mali.
  • Draguez B; Médecins Sans Frontières, Brussels, Belgium.
  • Duraffour S; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Enwere G; World Health Organization, Geneva, Switzerland.
  • Grais R; Epicentre, Paris, France.
  • Gunther S; WHO Collaborating Centre for Arboviruses and Hemorrhagic Fever Reference and Research, Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Hossmann S; Clinical Trials Unit, University of Bern, Bern, Switzerland.
  • Kondé MK; CEFORPAG, Conakry, Guinea.
  • Kone S; World Health Organization, Geneva, Switzerland.
  • Kuisma E; Public Health England, Porton Down, Wiltshire, UK; The European Mobile Laboratory Consortium, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Levine MM; Center for Vaccine Development, University of Maryland, Baltimore, MD, USA.
  • Mandal S; Public Health England, London, UK.
  • Norheim G; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Riveros X; World Health Organization, Geneva, Switzerland.
  • Soumah A; Epicentre, Paris, France.
  • Trelle S; Clinical Trials Unit, University of Bern, Bern, Switzerland.
  • Vicari AS; World Health Organization, Geneva, Switzerland.
  • Watson CH; Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Kéïta S; Ebola Response, Ministry of Health, Conakry, Guinea.
  • Kieny MP; World Health Organization, Geneva, Switzerland. Electronic address: kienym@who.int.
  • Røttingen JA; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway; Department of Health and Society, University of Oslo, Oslo, Norway; Department of Global Health and Population, Harvard T H Chan School of Public Health, Boston, MA, USA.
Lancet ; 386(9996): 857-66, 2015 Aug 29.
Article em En | MEDLINE | ID: mdl-26248676

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Vacinas contra Ebola Tipo de estudo: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Lancet Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Suíça